Page last updated: 2024-11-06

prednisolone and Graft vs Host Disease

prednisolone has been researched along with Graft vs Host Disease in 147 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research Excerpts

ExcerptRelevanceReference
"A prospective randomised trial was performed in patients given HLA-identical sibling bone marrow transplants for haematological malignancy comparing the combination of cyclosporin and methotrexate (CM) (n = 20) with the combination of cyclosporin, methotrexate and prednisolone (CMP) (n = 21) as prophylaxis for graft-versus-host disease (GVHD)."9.07A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy. ( Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S, 1991)
"Oral prednisolone was commenced on day +14 at 0."6.73Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants. ( Curtis, DJ; Grigg, AP; Hoyt, R; Macgregor, L; Ritchie, DS; Roberts, AW; Szer, J, 2008)
"Treatment with ursodeoxycholic acid (UDCA), subsequently added to the immunosuppressive therapy, apparently normalized the levels of biliary tract enzyme and total bilirubin."5.31Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid. ( Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O, 2002)
"Patients with non-viral infections seemed to have more depressed lymphocyte responses than non-infected patients."5.27Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections. ( Nilsson, B; Paulin, T; Ringdén, O, 1987)
"Mycophenolate mofetil (MMF), a new immunosuppressive drug successfully used in renal and heart transplant recipients, was used in combination with cyclosporin A (CsA), methotrexate (MTX) and prednisolone for the prophylaxis of acute graft-versus-host disease (aGVHD) after bone marrow transplantation (BMT) and peripheral blood stem cell transplantation (PBSCT) from human leukocyte antigen (HLA)-mismatched, unrelated (n = 9) and related donors (n = 4) in an open single-centre phase II study."5.09Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients. ( Basara, N; Bischoff, M; Blau, WI; Fauser, AA; Günzelmann, S; Kiehl, MG; Kirsten, D; Schmetzer, B, 2000)
"A prospective randomised trial was performed in patients given HLA-identical sibling bone marrow transplants for haematological malignancy comparing the combination of cyclosporin and methotrexate (CM) (n = 20) with the combination of cyclosporin, methotrexate and prednisolone (CMP) (n = 21) as prophylaxis for graft-versus-host disease (GVHD)."5.07A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy. ( Ashby, M; Atkinson, K; Biggs, J; Concannon, A; Dodds, A; Downs, K; Wilson, F; Young, S, 1991)
" Cyclosporine, methotrexate and prednisone were used for graft-versus-host disease (GVHD) prophylaxis."5.07Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide. ( Angelucci, E; Baronciani, D; Erer, B; Galimberti, M; Gaziev, D; Giardini, C; Lucarelli, G; Polchi, P; Rapa, S; Ripalti, M, 1994)
" She was diagnosed with myocarditis and successfully treated using prednisolone."5.05Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review. ( Hiroshima, Y; Kazumoto, H; Kirihara, T; Kitahara, M; Kobayashi, H; Sato, K; Shimizu, K; Shishido, T; Sumi, M; Ueki, T; Uematsu, N, 2020)
" However, on day 49 post transplantation, she presented with diarrhea due to gastrointestinal acute graft-versus-host disease (aGVHD), and treatments with prednisolone, budesonide rectal foam, and human mesenchymal stem cells were ineffective."4.31[Steroid-refractory gastrointestinal acute graft-versus-host disease treated with vedolizumab and ruxolitinib in a pediatric patient with therapy-related acute myeloid leukemia]. ( Kamimura, S; Kinoshita, M; Moritake, H; Nagasawa, S; Nishikawa, T; Okamoto, Y; Tanaka, H; Yamada, A, 2023)
" He did not have severe graft-versus-host disease, but he developed interstitial pneumonia six months after transplantation when his oral cyclosporine A (CsA) dose was reduced to 10 mg/day."4.31[Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy]. ( Akahoshi, Y; Date, H; Gomyo, A; Ishikawa, T; Kako, S; Kameda, K; Kanda, Y; Kawamura, M; Kawamura, S; Kimura, SI; Kusuda, M; Matsumi, S; Matsumoto, K; Matsuoka, A; Meno, T; Misaki, Y; Nakamura, Y; Nakasone, H; Okada, Y; Takeshita, J; Tamaki, M; Tanaka, S; Wada, H; Yoshimura, K; Yoshino, N, 2023)
" Graft-versus-host disease (GVHD) prophylaxis consisted of tacrolimus and short-term methotrexate."3.96A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation. ( Iwaki, N; Kurokawa, T; Maeda, Y; Mochizuki, K; Ozaki, J, 2020)
" While on cyclosporine A and prednisolone therapy for graft versus host disease, he developed extensive gingival, cutaneous, and respiratory tract human herpes virus-8-associated Kaposi sarcoma (KS)."3.78Extensive gingival and respiratory tract Kaposi sarcoma in a child after allogenic hematopoietic stem cell transplantation. ( Abbas, AA; Jastaniah, WA, 2012)
" She was being treated with tacrolimus, methotrexate and prednisolone for prophylaxis and treatment of graft-versus-host disease, and with intensive insulin therapy for better glycemic control."3.78Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation. ( Akashi, K; Fukagawa, S; Furue, M; Miyamoto, T; Moroi, Y; Sugiyama, A; Takeuchi, S; Yoshimoto, G, 2012)
" The patient had been administered steroid and cyclosporine for chronic graft-versus-host disease."3.77[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation]. ( Inagaki, J; Nagatoshi, Y; Nomura, Y; Okamura, J; Sakiyama, M; Teranishi, H; Yanai, F, 2011)
" Graft-versus-host disease (GVHD) prophylaxis was a continuous infusion of either tacrolimus 0."3.74Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases. ( Hamaki, T; Hori, A; Kami, M; Kanda, Y; Kusumi, E; Masuoka, K; Matsumura, T; Miyakoshi, S; Murashige, N; Tanaka, Y; Taniguchi, S; Uchida, N; Wake, A; Yuji, K, 2007)
" Graft-versus-host disease prophylaxis consisted of cyclosporine plus methotrexate or prednisolone."3.74Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents. ( Remberger, M; Ringdén, O, 2007)
" On day +42, 1 mg/kg per day of prednisolone therapy was initiated for grade III acute graft-versus-host disease (GVHD)."3.73Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia. ( Asano, S; Fukuno, K; Iseki, T; Konuma, T; Moriwaki, H; Ooi, J; Takahashi, S; Takasugi, K; Tojo, A; Tomonari, A; Tsukada, N, 2006)
"Patients receiving prednisolone as a prophylaxis of acute graft-versus-host disease had lower number of NK cells compared to those not given steroids prophylactically (110(10-694) vs."3.73The impact of immunosuppressive therapy on an early quantitative NK cell reconstitution after allogeneic haematopoietic cell transplantation. ( Dziaczkowska, J; Giebel, S; Holowiecki, J; Jagoda, K; Krawczyk-Kulis, M; Kruzel, T; Markiewicz, M; Nowak, K; Wojnar, J; Wylezol, I, 2005)
" Risk factors for SIADH included young age, transplantation from an HLA-mismatched or unrelated donor, cord blood transplantation, and graft-versus-host disease prophylaxis with methyl prednisolone."3.72Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation. ( Iguchi, A; Kaneda, M; Kobayashi, K; Kobayashi, R; Kuroki, F; Mino, E; Nakajima, M; Sato, T; Suzuki, Y; Yoshida, M, 2004)
" Prophylaxis against graft-versus-host disease (GVHD) consisted of cyclosporine (CsA) and short-term methotrexate."3.72[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation]. ( Koyama, M; Kunisaki, Y; Matsue, K; Matsuoka, K; Takeuchi, M, 2004)
" On post-transplantation day 83 he was diagnosed as having upper gastrointestinal graft-versus-host disease (GVHD) by endoscopic examination and pathological examination of endoscopic biopsy specimens, and daily administration of 60 mg of water-soluble prednisolone and 50 mg of cyclosporine was started."3.71Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation. ( Chiba, T; Fujii, S; Nakase, H; Nishi, T; Nishihara, T; Ohana, M; Okazaki, K; Uchida, K; Uose, S, 2001)
" Graft-versus-host disease (GVHD) prophylaxis was cyclosporin, prednisolone and low-dose antithymocyte globulin."3.70Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin. ( Haghshenas, M; Khojasteh, HN; Ramzi, M; Zakerinia, M, 1999)
" All patients were treated with high-dose prednisolone, 16 for severe acute or extensive chronic graft-versus-host disease (GVHD) and one patient for graft rejection."3.70Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options. ( Böhm, P; Einsele, H; Faul, C; Kanz, L; Pereira, P; Wiesmann, A, 1998)
" He sustained hematologic and cytogenetic remission, but severe graft-versus-host disease (GVHD) developed for which cyclosporin A and prednisolone were required."3.69Donor buffy coat infusions for a patient with myelodysplastic syndrome who relapsed following allogeneic bone marrow transplantation. ( Ezaki, K; Hirano, M; Kojima, H; Maruyama, F; Tsuzuki, M, 1995)
" Cyclosporin A and methotrexate had been administered to prevent graft-versus-host disease."3.69Cold agglutinin disease following allogeneic bone marrow transplantation. ( Fujita, H; Hashimoto, Y; Hataoka, K; Kanamori, H; Maeda, K; Ohtsuka, M; Okamoto, R; Tamura, T; Tanabe, J; Yamazaki, E, 1994)
" Grade III acute GVHD (graft-versus-host disease) occurred 35 d after DLT which was fully reversed with cyclosporin and prednisolone."3.69Donor leucocyte transfusions for relapse in myelodyplastic syndrome after allogeneic bone marrow transplantation. ( Okumura, H; Takamatsu, H; Yoshida, T, 1996)
" This occurred during an exacerbation of graft-versus-host disease (GVHD) and both problems remitted after therapy with cyclosporine and prednisolone."3.68Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient. ( Barbara, JA; Gillis, D; Ho, JO; Smith, PS; Thomas, AC; Woodroffe, AJ, 1992)
"Prednisolone as preemptive treatment did not lead to an increase in relapse (20."3.01A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy. ( Baurmann, H; Bethge, W; Beutel, G; Bunjes, DW; Ehrlich, S; Ganser, A; Hambach, L; Hamwi, I; Heidenreich, D; Holler, E; Jonigk, D; Klein, S; Krauter, J; Kreipe, HH; Messinger, D; Metzger, J; Papkalla, A; Raad, J; Rank, A; Schäfer-Eckart, K; Schetelig, J; Schleuning, M; Schmid, C; Stadler, M; Stolzl, F; Türüchanow, I; von der Leyen, H; von Harsdorf, S; Wagner-Drouet, EM; Weissinger, EM; Westphal, K, 2021)
" Whereas systemic exposure to budesonide was markedly lower in healthy subjects after the mouthwash compared to oral dosing (mean relative bioavailability 18%-36%), the systemic concentrations thereafter in patients were as high as those after the identical dose of oral budesonide."2.74Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease. ( Bertz, H; Dilger, K; Finke, J; Gratwohl, A; Halter, J; Lopez-Lazaro, L, 2009)
"Oral prednisolone was commenced on day +14 at 0."2.73Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants. ( Curtis, DJ; Grigg, AP; Hoyt, R; Macgregor, L; Ritchie, DS; Roberts, AW; Szer, J, 2008)
" Due to lack of evidence, inclusion criteria was revised during the process of the review to include studies comparing different dosage of corticosteroids."2.46Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation. ( Banihosseini, S; Ferrara, JL; Rabbani-Anari, M; Rahimi Darabad, R; Rohanizadegan, M; Salmasian, H; Shakiba, A, 2010)
" Optimizing prednisone (and prednisolone) dosing by measuring their concentrations and calculating their pharmacokinetic parameters will allow for personalized treatments for patients, producing more effective and safer treatments for GVHD."2.44Simultaneous Determination of Prednisone and Prednisolone in Serum by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry. ( Carlow, DC; Schofield, RC; Scordo, M; Shah, G, 2024)
"At 4 years old he was diagnosed with acute lymphoblastic leukemia and underwent bone marrow transplantation."1.38Early occurrence of nephrotic syndrome associated with cord blood stem cell transplantation. ( Furuya, A; Ida, K; Igarashi, T; Koh, K; Miura, K; Sekine, T; Takamizawa, M; Takita, J; Terashima, H, 2012)
"The renal biopsy showed type I membranoproliferative glomerulonephritis."1.36Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation. ( Chang, YS; Chung, S; Kim, B; Kim, JY; Lee, MY; Park, CW, 2010)
"Polymyositis is a rare manifestation of cGvHD in adult patients following allogeneic BMT."1.34Polymyositis--an unusual presentation of cGvHD in children. ( Duffner, U; Ehl, S; Franck, P; Klein, R; Niemeyer, CM; Schmitt-Graeff, A, 2007)
"Treatment of severe aplastic anemia (SAA) patients who lack human leukocyte antigen (HLA)-matched donors and failed immunosuppressive therapy (IST) is challenging."1.33Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning. ( Goto, K; Hara, T; Hattori, S; Ichino, K; Nakamura, K; Nomura, A; Ohga, S; Takada, H, 2006)
"A 44-year-old woman with refractory follicular lymphoma underwent allogeneic stem cell transplantation (SCT) and achieved complete remission."1.33Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma. ( Aisa, Y; Amagai, M; Ikeda, Y; Mori, T; Nakazato, T; Okamoto, S; Yamagami, J; Yamazaki, R, 2005)
"A 31-year-old woman with acute myeloblastic leukemia (AML) underwent allogeneic peripheral blood stem cell transplant (PBSCT)."1.32Pericarditis associated with Epstein-Barr virus reactivation in a patient following allogeneic peripheral blood stem cell transplantation from an HLA genotypic 1-locus mismatched sibling donor. ( Aoyama, Y; Hino, M; Nakamae, H; Nakao, Y; Ohta, K; Sakai, T; Yamamura, R; Yamane, T, 2004)
"Lithium carbonate was effective for the treatment of depressive disorder without causing side effects such as renal dysfunction."1.32Successful lithium carbonate treatment for steroid-induced depression following bone marrow transplantation: a case report. ( Fujisawa, S; Ito, M; Kanamori, H; Onishi, H; Onose, M; Yamada, T, 2003)
"Treatment with ursodeoxycholic acid (UDCA), subsequently added to the immunosuppressive therapy, apparently normalized the levels of biliary tract enzyme and total bilirubin."1.31Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid. ( Chiba, T; Fukai, K; Imazeki, F; Kanda, T; Nishimura, M; Saisho, H; Saito, Y; Yokosuka, O, 2002)
"Liver dysfunction is a common problem in BMT recipients and it is important to determine the etiology in order to institute appropriate therapy."1.31Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study. ( Chung, KW; Kang, CS; Kim, BK; Kim, CC; Min, WS; Shin, WS; Sim, SI; Suh, JG; Sun, HS, 2000)
"However, the dry eye worsened while tapering FK506, with no flare of other affected organs."1.31Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids. ( Kuwana, M; Mashima, Y; Mori, T; Nakajima, T; Ogawa, Y; Oguchi, Y; Okamoto, S; Tsubota, K; Watanabe, R; Yamada, M, 2001)
"Three patients with refractory multiple myeloma (MM) underwent related allo-BMT."1.31[Allogeneic bone marrow transplantation for refractory multiple myeloma: presence of a graft-versus-myeloma effect]. ( Hara, M; Kojima, K; Nawa, Y; Noguchi, T, 2001)
"Tresperimus (LF-08-0299) is an immunosuppressant under development by Laboratoires Fournier for its potential use in organ transplant rejection."1.31Tresperimus (Laboratoires Fournier). ( Elices, MJ, 2001)
"A 26-year-old male with acute lymphoblastic leukemia (ALL) in its second complete remission received an unrelated bone marrow transplantation (UBMT) following cyclophosphamide plus total body irradiation conditioning."1.31A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT. ( Nakaseko, C; Nishimura, M; Saito, Y; Uehara, T; Yokota, A, 2002)
"Autoimmune haemolytic anaemia is also recognised, is frequently difficult to treat and overall prognosis is often poor, usually from associated problems."1.31Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation. ( Kinsey, SE; Pratt, G, 2001)
" The lower variability of trough levels and the higher L/D ratio in the CyE group, which are related ti improved bioavailability of CyE, may explain the lower rejection rate among these patients."1.30Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation. ( Haberal, M; Karakayali, H; Moray, G; Senel, FM; Yildirim, S, 1997)
"A 29-year-old man with severe aplastic anemia (SAA) was submitted to HLA-identical unrelated allogeneic bone marrow transplantation (BMT) and was found to be suffering from grade IV G-I GVHD."1.30Intra-mesenteric artery steroid administration relieved severe refractory gastro-intestinal graft-vs.-host disease in an allogeneic bone marrow transplantation patient. ( Honma, H; Kato, J; Kogawa, K; Kuribayashi, K; Morii, K; Nagamachi, Y; Nagaoka, Y; Niitsu, Y; Sakamaki, S; Sato, T, 1997)
"An 18-year-old man with severe aplastic anemia underwent an allogeneic BMT using his HLA-identical sister."1.30A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation. ( Choi, KS; Chung, IJ; Hwang, TJ; Kim, HJ; Kook, H; Lee, JJ; Park, MR; Seo, JS, 1998)
"A 37-year-old Japanese man with chronic myeloid leukemia (CML) developed myasthenia gravis 29 months after bone marrow transplantation (BMT) from an HLA one locus-mismatched brother."1.29Myasthenia gravis after allogeneic bone marrow transplantation. ( Gondo, H; Harada, M; Nakamura, M; Niho, Y; Okamura, S; Otsuka, T; Sano, T; Shimoda, K, 1994)
"Patients with non-viral infections seemed to have more depressed lymphocyte responses than non-infected patients."1.27Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections. ( Nilsson, B; Paulin, T; Ringdén, O, 1987)
"Patients with severe aplastic anaemia received cyclophosphamide (4 X 50 mg/kg) and fractionated total nodal irradiation (total dose 8 Gy)."1.27[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center]. ( Brix, F; Dühmke, E; Euler, HH; Gassmann, W; Gremmel, H; Hebbinghaus, D; Kayser, W; Schaub, J; Schmitz, N; Wüstemann, M, 1985)

Research

Studies (147)

TimeframeStudies, this research(%)All Research%
pre-199017 (11.56)18.7374
1990's34 (23.13)18.2507
2000's51 (34.69)29.6817
2010's36 (24.49)24.3611
2020's9 (6.12)2.80

Authors

AuthorsStudies
Tsuji, K2
Spears, GW1
Nakamura, K2
Tojo, T1
Seki, N1
Sugiyama, A2
Matsuo, M1
Mitani, K1
Hida, S1
Fujino, H1
Sumimoto, S1
Nagasawa, S1
Yamada, A1
Kinoshita, M1
Kamimura, S1
Tanaka, H1
Nishikawa, T1
Okamoto, Y1
Moritake, H1
Nakamura, Y1
Kawamura, S1
Matsumi, S1
Matsumoto, K1
Tanaka, S1
Ishikawa, T2
Matsuoka, A1
Meno, T1
Kawamura, M2
Takeshita, J1
Yoshino, N1
Yoshimura, K1
Misaki, Y1
Gomyo, A1
Okada, Y1
Tamaki, M2
Kusuda, M1
Akahoshi, Y1
Kameda, K1
Wada, H2
Kimura, SI1
Nakasone, H1
Kako, S1
Date, H1
Kanda, Y2
Schofield, RC1
Scordo, M1
Shah, G1
Carlow, DC1
Sumi, M1
Kitahara, M1
Shishido, T1
Kazumoto, H1
Uematsu, N1
Kirihara, T1
Sato, K1
Ueki, T1
Hiroshima, Y1
Shimizu, K1
Kobayashi, H2
Iwaki, N1
Mochizuki, K2
Ozaki, J1
Maeda, Y1
Kurokawa, T1
Weissinger, EM1
Metzger, J1
Schleuning, M1
Schmid, C1
Messinger, D1
Beutel, G1
Wagner-Drouet, EM1
Schetelig, J1
Baurmann, H1
Rank, A1
Stolzl, F1
Schäfer-Eckart, K1
Westphal, K1
Bethge, W1
von Harsdorf, S1
Bunjes, DW1
Heidenreich, D1
Klein, S1
Holler, E3
Kreipe, HH1
Jonigk, D1
Türüchanow, I1
Raad, J1
Papkalla, A1
von der Leyen, H1
Hambach, L2
Hamwi, I1
Ehrlich, S1
Krauter, J1
Stadler, M2
Ganser, A3
Schmitz, N3
Truemper, L1
Bouabdallah, K1
Ziepert, M1
Leclerc, M1
Cartron, G1
Jaccard, A1
Reimer, P1
Wagner, E1
Wilhelm, M1
Sanhes, L1
Lamy, T1
de Leval, L1
Rosenwald, A1
Roussel, M1
Kroschinsky, F1
Lindemann, W1
Dreger, P2
Viardot, A1
Milpied, N2
Gisselbrecht, C1
Wulf, G1
Gyan, E1
Gaulard, P1
Bay, JO1
Glass, B1
Poeschel, V1
Damaj, G1
Sibon, D1
Delmer, A1
Bilger, K1
Banos, A1
Haenel, M1
Dreyling, M1
Metzner, B1
Keller, U1
Braulke, F1
Friedrichs, B1
Nickelsen, M1
Altmann, B1
Tournilhac, O1
Ciullini Mannurita, S1
Goda, R1
Schiavo, E1
Coniglio, ML1
Azzali, A1
Fotzi, I1
Tondo, A1
Tintori, V1
Frenos, S1
Sanvito, MC1
Vignoli, M1
Luceri, C1
Bigagli, E1
Grassi, A1
D'Elios, MM1
Favre, C1
Gambineri, E1
McDonald, GB1
Tabellini, L1
Storer, BE1
Martin, PJ2
Lawler, RL1
Rosinski, SL1
Schoch, HG1
Hansen, JA1
Kitamura, N1
Nakanishi, T1
Yoshida, Y1
Higashi, T1
Tsukada, J1
Eisenga, MF1
Dullaart, RPF1
Berger, SP1
Touw, DJ1
Bakker, SJL1
Gaillard, CAJM1
Sano, H1
Kobayashi, S1
Ohara, Y1
Ito, M2
Waragai, T1
Takahashi, N1
Ikeda, K1
Ohto, H1
Kikuta, A1
Reinhardt-Heller, K1
Hirschberg, I1
Vogl, T1
Handgretinger, R1
Holzer, U1
van Zelm, MC1
Pumar, M1
Shuttleworth, P1
Aui, PM1
Smart, JM1
Grigg, A1
Bosco, JJ1
Kleiter, I1
Poeschl, P1
Kraus, PD1
Huber, E1
Schröder, J1
Schulte-Mattler, W1
Wolff, D2
Chu, GY1
Lin, HL1
Chen, GS1
Wu, CY1
Olivieri, A1
Cimminiello, M1
Corradini, P1
Mordini, N1
Fedele, R1
Selleri, C1
Onida, F1
Patriarca, F1
Pavone, E1
Svegliati, S1
Gabrielli, A1
Bresciani, P1
Nuccorini, R1
Pascale, S1
Coluzzi, S1
Pane, F1
Poloni, A1
Olivieri, J1
Leoni, P1
Bacigalupo, A2
Minculescu, L1
Madsen, HO1
Sengeløv, H1
Inamoto, Y2
Asari, S1
Matsumoto, I1
Toyama, H1
Shinzeki, M1
Goto, T3
Tanaka, M1
Shirakawa, S1
Yamashita, H1
Ajiki, T1
Fukumoto, T1
Ku, Y1
Sun, YC1
Chai, X1
Pidala, J1
Flowers, ME1
Shen, TT1
Lee, SJ1
Jagasia, M1
Muroi, K1
Miyamura, K1
Okada, M2
Yamashita, T1
Murata, M1
Uike, N1
Hidaka, M1
Kobayashi, R2
Imamura, M1
Tanaka, J1
Ohashi, K2
Taniguchi, S2
Ikeda, T1
Eto, T1
Mori, M1
Yamaoka, M1
Ozawa, K1
Nozaki, K1
Onishi, M1
Yamamoto, K1
Ujiie, H1
Sugahara, H1
Ikebe, T1
Takata, H1
Sasaki, H1
Miyazaki, Y1
Ohtsuka, E1
Saburi, Y1
Ogata, M1
Shirao, K1
Yesilipek, MA1
Tezcan, G1
Germeshausen, M1
Kupesiz, A1
Uygun, V1
Hazar, V1
Dilger, K1
Halter, J1
Bertz, H1
Lopez-Lazaro, L1
Gratwohl, A2
Finke, J2
Landfried, K1
Cheng, FW1
Lee, V1
To, KF1
Chan, KC1
Shing, MK1
Li, CK1
Adenis-Lamarre, E1
Fricain, JC1
Tabrizi, R1
Turlure, P1
Beylot-Barry, M1
Salmasian, H1
Rohanizadegan, M1
Banihosseini, S1
Rahimi Darabad, R1
Rabbani-Anari, M1
Shakiba, A1
Ferrara, JL1
Saruwatari, H1
Yoshifuku, A1
Kawai, K1
Kanekura, T1
Kawakami, T1
Takimoto, M1
Soma, Y1
Kim, JY1
Lee, MY1
Kim, B1
Park, CW1
Chang, YS1
Chung, S1
Ukena, SN1
Grosse, J1
Mischak-Weissinger, E1
Buchholz, S1
Franzke, A1
El Cheikh, J1
Castagna, L1
Wang, L1
Esterni, B1
Faucher, C1
Furst, S1
Duran, S1
Berger, P1
Ranque, S1
Mohty, M1
Blaise, D1
Nishida, S1
Kawasaki, T1
Kashiwagi, H1
Morishima, A1
Hishitani, Y1
Kawai, M1
Hirano, T1
Ishii, T2
Hagihara, K2
Shima, Y1
Narazaki, M1
Ogata, A1
Oka, Y2
Kishimoto, T1
Tanaka, T1
Teranishi, H1
Sakiyama, M1
Nagatoshi, Y2
Nomura, Y1
Inagaki, J1
Yanai, F1
Okamura, J1
Ohta, H1
Miyashita, E1
Hirata, I1
Matsumura, R1
Yoshida, H1
Hashii, Y1
Higashiura, T1
Yasumi, T1
Murata, Y1
Heike, T1
Yang, X1
Kanegane, H1
Ohara, O1
Ozono, K1
Yuksekkaya, HA1
Arikan, C1
Tumgor, G1
Aksoylar, S1
Kilic, M1
Aydogdu, S1
Takeuchi, S1
Fukagawa, S1
Moroi, Y1
Yoshimoto, G1
Miyamoto, T1
Akashi, K2
Furue, M1
Miura, K1
Sekine, T1
Takamizawa, M1
Terashima, H1
Furuya, A1
Koh, K1
Takita, J1
Ida, K1
Igarashi, T1
Abbas, AA1
Jastaniah, WA1
Yoshimi, A2
Yamamoto, G1
Koike, K1
Kurokawa, M3
Fløisand, Y1
Brinch, L2
Gedde-Dahl, T1
Tjønnfjord, GE1
Dybedal, I1
Holte, H1
Heldal, D1
Torfoss, D1
Aurlien, E1
Lauritzsen, GF1
Fosså, A1
Lehne, G1
Baggerød, E1
Kvalheim, G1
Egeland, T1
Bishop, MR2
Fowler, DH1
Kolstad, A1
Miyauchi, M1
Nannya, Y1
Takazawa, Y1
Ichikawa, M1
Fukayama, M1
Mian, M1
Farsad, M1
Pescosta, N1
Casini, M1
Cavattoni, IM1
Deola, S1
Cortelazzo, S1
Dietrich, S1
Falk, CS1
Benner, A1
Karamustafa, S1
Hahn, E1
Andrulis, M1
Hegenbart, U1
Ho, AD1
Luft, T1
Wong, S1
Rasalkar, DD1
Paunipagar, BK1
Okubo, H1
Nagata, N1
Uemura, N1
Uehara, T1
Nakaseko, C1
Yokota, A1
Saito, Y2
Nishimura, M3
Suehiro, T1
Masutani, K1
Yokoyama, M1
Tokumoto, M1
Tsuruya, K1
Fukuda, K1
Kanai, H1
Katafuchi, R1
Hirakata, H1
Murotani, Y1
Kuroda, J1
Kimura, S1
Terao, K1
Fukiya, E1
Ozawa, M1
Kobayashi, Y1
Yoshikawa, T1
Svahn, BM1
Remberger, M2
Myrbäck, KE1
Holmberg, K1
Eriksson, B1
Hentschke, P1
Aschan, J1
Barkholt, L1
Ringdén, O3
Chiba, T2
Yokosuka, O1
Kanda, T1
Fukai, K1
Imazeki, F1
Saisho, H1
Onose, M1
Yamada, T1
Onishi, H1
Fujisawa, S1
Kanamori, H2
Kircher, B1
Lätzer, K1
Gastl, G1
Nachbaur, D1
Mandigers, CM1
Verdonck, LF1
Meijerink, JP1
Dekker, AW1
Schattenberg, AV1
Raemaekers, JM1
Cantisani, V1
Mortele, KJ1
Viscomi, SG1
Glickman, J1
Silverman, SG1
Ros, PR1
Robinson, MR1
Lee, SS1
Rubin, BI1
Wayne, AS1
Pavletic, SZ1
Childs, R1
Barrett, AJ1
Csaky, KG1
Aoyama, Y1
Nakao, Y1
Ohta, K2
Sakai, T1
Nakamae, H2
Yamamura, R1
Yamane, T2
Hino, M2
Lee, WY1
Baek, KH1
Rhee, EJ1
Tae, HJ1
Oh, KW1
Kang, MI1
Lee, KW1
Kim, SW1
Kim, CC2
Oh, ES1
Hirokawa, M1
Miura, I1
Sawada, K1
Iguchi, A1
Nakajima, M1
Sato, T2
Yoshida, M1
Kaneda, M1
Suzuki, Y1
Mino, E1
Kuroki, F1
Kobayashi, K1
Koyama, M1
Matsuoka, K1
Kunisaki, Y1
Takeuchi, M1
Matsue, K1
Endo, M1
Furukawa, H1
Aramaki, T1
Morimoto, N1
Uematsu, T1
Yukisawa, S1
Yuen, S1
Yamamoto, N1
Ohde, Y1
Kondo, H1
Amano, K1
Chuhjo, T1
Shiobara, S1
Aisa, Y1
Mori, T2
Nakazato, T1
Yamazaki, R1
Yamagami, J1
Amagai, M1
Ikeda, Y2
Okamoto, S3
Giebel, S1
Dziaczkowska, J1
Wojnar, J1
Krawczyk-Kulis, M1
Markiewicz, M1
Kruzel, T1
Wylezol, I1
Nowak, K1
Jagoda, K1
Holowiecki, J1
Kontny, U1
Boppana, S1
Jung, A1
Goebel, H1
Strahm, B1
Peters, A1
Dormann, S1
Werner, M1
Bader, P1
Fisch, P1
Niemeyer, C1
Himuro, K1
Terada, Y1
Sakamoto, E1
Takeoka, Y1
Nakane, T1
Nakamae, M1
Shimada, H1
Miki, T1
Ohga, S1
Ichino, K1
Goto, K1
Hattori, S1
Nomura, A1
Takada, H1
Hara, T2
Lin, PC1
Hsiao, LT1
Chen, PM1
Fukuno, K2
Tomonari, A2
Takahashi, S2
Ooi, J2
Takasugi, K2
Tsukada, N2
Konuma, T2
Iseki, T1
Moriwaki, H1
Tojo, A2
Asano, S2
Klein, R1
Franck, P1
Ehl, S1
Schmitt-Graeff, A1
Duffner, U1
Niemeyer, CM1
Ashida, T1
Mayama, T1
Higashishiba, M1
Kawanishi, K1
Miyatake, J1
Tatsumi, Y1
Kanamaru, A3
Izumi, R1
Fujimoto, M1
Yazawa, N1
Nakashima, H1
Asashima, N1
Watanabe, R3
Kuwano, Y1
Hashimoto, T1
Tamaki, K1
Kobayashi, T1
Fujii, T1
Endo, T1
Iwamoto, A1
Oyaizu, N1
Asanoa, S1
Miyakoshi, S1
Kusumi, E1
Matsumura, T1
Hori, A1
Murashige, N1
Hamaki, T1
Yuji, K1
Uchida, N1
Masuoka, K1
Wake, A1
Kami, M1
Tanaka, Y1
Jinta, M1
Ohta, T1
Ieki, R1
Abe, K1
Kamata, N1
Akiyama, H1
Sakamaki, H1
Hoyt, R1
Ritchie, DS1
Roberts, AW1
Macgregor, L1
Curtis, DJ1
Szer, J2
Grigg, AP2
Taube, DH1
Williams, DG1
Cameron, JS1
Bewick, M1
Ogg, CS1
Rudge, CJ1
Welsh, KI1
Kennedy, LA1
Thick, MG1
Tampi, R1
Barr, AL1
Zilko, PJ1
Nikoskelainen, J1
Söderström, KO1
Rajamäki, A1
Meurman, L1
Korvenranta, H1
Kalliomäki, JL1
Toivanen, A1
Doney, KC1
Weiden, PL2
Storb, R2
Thomas, ED2
Hebart, H1
Ehninger, G1
Schmidt, H1
Berner, B1
Reuss-Borst, M1
Waller, HD1
Müller, CA1
Einsele, H2
Takemoto, Y2
Kakishita, E2
Dohy, H1
Kodera, Y1
Moriyama, Y1
Shibata, A1
Kasai, M1
Katoh, S1
Saitoh, H1
Koehler, MT1
Howrie, D1
Mirro, J1
Neudorf, S1
Blatt, J1
Corey, S1
Wollman, M1
Kelly-Ekeroth, V1
Reyes, J1
Vreugdenhil, G1
Schattenberg, A1
Dompeling, EC1
Swaak, AJ1
De Witte, T1
Shimoda, K1
Gondo, H2
Harada, M2
Sano, T1
Nakamura, M1
Otsuka, T1
Okamura, S1
Niho, Y2
Tamura, T1
Yamazaki, E1
Ohtsuka, M1
Hataoka, K1
Maeda, K1
Okamoto, R1
Tanabe, J1
Fujita, H1
Hashimoto, Y1
Galimberti, M1
Polchi, P1
Lucarelli, G1
Angelucci, E1
Baronciani, D1
Giardini, C1
Gaziev, D1
Erer, B1
Ripalti, M1
Rapa, S1
Hamon, MD1
Gale, RF1
Macdonald, ID1
Smith, OP1
Collis, CH1
Skeggs, DB1
Gandhi, L1
Prentice, HG1
Weisdorf, D1
Filipovich, A1
McGlave, P1
Ramsay, N1
Kersey, J1
Miller, W1
Blazar, B1
Ohtaka, M1
Suzuki, A1
Gotoh, A1
Nagasu, M1
Torii, Y1
Kimura, Y1
Ichinose, Y1
Toyama, K1
Serizawa, H1
Ebihara, Y2
Hara, N1
Harada, N1
Asou, N1
Hayashi, S1
Minematsu, T1
Minamishima, Y1
Tsuzuki, M1
Maruyama, F1
Kojima, H1
Ezaki, K1
Hirano, M1
Okumura, H1
Takamatsu, H1
Yoshida, T1
Labopin, M1
Majolino, I1
Laporte, JP1
Cook, G1
Lambertenghi-Deliliers, G1
Lange, A1
Rozman, C1
Garcia-Conde, J1
Domingo-Albos, A1
Gruessner, RW1
Fasola, C1
Fryer, J1
Nakhleh, RE1
Kim, S1
Gruessner, AC1
Beebe, D1
Moon, C1
Troppmann, C1
Najarian, JS1
Azuno, Y1
Kaneko, T1
Okuya, S1
Nakai, K1
Nomiyama, J1
Mori, K1
Okafuji, K1
Okubo, M1
Matsutani, A1
Kamei, S1
Zaitsu, Y1
Takeuchi, Y1
Kaku, K1
Gallardo, D1
Ferrà, C1
Berlanga, JJ1
Banda, ED1
Ponce, C1
Salar, A1
Alonso, E1
Espanñol, I1
Riu, C1
Grañena, A1
Gerber, M1
Gmeinhart, B1
Volc-Platzer, B1
Kalhs, P1
Greinix, H1
Knobler, R1
Ohashi, Y1
Minegishi, M1
Fujie, H1
Tsuchiya, S1
Konno, T1
Senel, FM1
Yildirim, S1
Karakayali, H1
Moray, G1
Haberal, M1
Sakamaki, S1
Nagaoka, Y1
Kuribayashi, K1
Nagamachi, Y1
Morii, K1
Honma, H1
Kogawa, K1
Kato, J1
Niitsu, Y1
Kim, HJ1
Chung, IJ1
Lee, JJ1
Seo, JS1
Park, MR1
Choi, KS1
Kook, H1
Hwang, TJ1
Basara, N3
Blau, WI3
Römer, E2
Rudolphi, M2
Bischoff, M3
Kirsten, D3
Sanchez, H2
Günzelmann, S3
Fauser, AA3
Wiesmann, A1
Pereira, P1
Böhm, P1
Faul, C1
Kanz, L1
Kiehl, MG2
Brandenburg, U1
Gottlieb, D1
Bradstock, K1
Ebeling, PR1
Thomas, DM1
Erbas, B1
Hopper, JL1
Wakui, M1
Ishida, A1
Yajima, T1
Iwao, Y1
Hisamatsu, T1
Hibi, T1
Okamoto, T2
Yamada, S2
Itoh, T2
Mori, A1
Saheki, K1
Takatsuka, H1
Tamura A, Y1
Fujimori, Y2
Schmetzer, B1
Khojasteh, HN1
Zakerinia, M1
Ramzi, M1
Haghshenas, M1
Takada, S1
Hatsumi, N1
Saito, T1
Matsushima, T1
Sakura, T1
Tamura, J1
Karasawa, M1
Miyawaki, S1
Kim, BK1
Chung, KW1
Sun, HS1
Suh, JG1
Min, WS1
Kang, CS1
Sim, SI1
Shin, WS1
Manabe, A1
Ueda, T1
Yoshino, H1
Mitsui, T1
Hisakawa, H1
Yagasaki, H1
Kikuchi, A1
Yoshimasu, T1
Tanaka, R1
Takahashi, T1
Masunaga, A1
Sugita, KI1
Nakahata, T1
Ogawa, Y1
Kuwana, M1
Nakajima, T1
Yamada, M1
Mashima, Y1
Tsubota, K1
Oguchi, Y1
Nawa, Y1
Noguchi, T1
Kojima, K1
Hara, M1
Elices, MJ1
Yasumi, M1
Karasuno, T1
Kanashima, H1
Masaie, H1
Taniguchi, H1
Mitsui, H1
Nakamura, H1
Hiraoka, A1
Nishi, T1
Okazaki, K1
Fujii, S1
Uchida, K1
Uose, S1
Nakase, H1
Ohana, M1
Nishihara, T1
Eder, M1
Dammann, E1
Battmer, K1
Stucki, A1
Heil, G1
Hertenstein, B1
Okano, A1
Shimazaki, C1
Ochiai, N1
Hatsuse, M1
Takahashi, R1
Ashihara, E1
Inaba, T1
Fujita, N1
Noda, Y1
Nakagawa, M1
Pratt, G1
Kinsey, SE1
Suminoe, A1
Matsuzaki, A1
Hattori, H1
Ishii, S1
Doney, K1
Barbara, JA1
Thomas, AC1
Smith, PS1
Gillis, D1
Ho, JO1
Woodroffe, AJ1
Hatta, Y1
Tomura, K1
Baba, M1
Horie, T1
Atkinson, K1
Biggs, J1
Concannon, A1
Dodds, A1
Young, S1
Wilson, F1
Ashby, M1
Downs, K1
Uharek, L1
Gassmann, W2
Fleischhauer, D1
Wottge, HU1
Loeffler, H1
Mueller-Ruchholtz, W1
Kino, T1
Hatanaka, H1
Hashimoto, M1
Nishiyama, M1
Okuhara, M1
Kohsaka, M1
Aoki, H1
Imanaka, H1
Cain, GR1
Champlin, R1
Jain, N1
Sullivan, KM1
Takanashi, M1
Masuda, M1
Motoji, T1
Oshimi, K1
Mizoguchi, H1
Osada, K1
Shimizu, M1
Mori, S1
Paulin, T1
Nilsson, B1
Shinohara, Y1
Kai, S1
Misawa, M1
Kohsaki, M1
Ifuku, H1
Ohe, Y1
Hara, H1
Popovic, S1
Bartlett, RR1
Kayser, W1
Euler, HH1
Wüstemann, M1
Brix, F1
Dühmke, E1
Hebbinghaus, D1
Gremmel, H1
Schaub, J1
Debusscher, L1
Bron, D1
Stryckmans, P1
Pichlmaier, H1
Griss, P1
Heilmann, K1
Wegener, K1
Ditzen, K1
Enger, E1
Bergan, F1
Hoeg, K1
Malm, OJ1
Thorsby, E1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Allo-allo Tandem Matched Stem Cell Transplantation (AATT) for the Treatment of Patients With Refractory Acute Leukemia; a Feasibility Phase I/II Study[NCT00984412]Phase 1/Phase 215 participants (Anticipated)Interventional2009-11-30Recruiting
TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study[NCT03272854]606 participants (Actual)Observational [Patient Registry]2001-08-31Active, not recruiting
An Investigator Initiated Open Study to Evaluate the Efficacy and Safety of Intra Arterial Infusion for Treatment of Steroid Resistant Acute Hepatic Graft Versus Host Disease (AGVHD)[NCT01140984]2 participants (Actual)Interventional2010-09-30Terminated (stopped due to technical issues)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

14 reviews available for prednisolone and Graft vs Host Disease

ArticleYear
Myocarditis with Advanced Atrioventricular Block after Allogeneic Stem Cell Transplantation: A Case Report and Literature Review.
    Internal medicine (Tokyo, Japan), 2020, Jan-01, Volume: 59, Issue:1

    Topics: Atrioventricular Block; Cord Blood Stem Cell Transplantation; Female; Glucocorticoids; Graft vs Host

2020
[Diagnosis and management of chronic graft-versus-host disease].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antibodies, Monoclonal, Murine-Derived; Bilirubin; Biomarkers; Calcineurin; Chronic Disease; Drug Th

2014
Acute graft-versus-host disease following simultaneous pancreas-kidney transplantation: report of a case.
    Surgery today, 2015, Volume: 45, Issue:12

    Topics: Acute Disease; Adolescent; Adult; Diabetes Mellitus, Type 1; Fatal Outcome; Female; Graft vs Host Di

2015
Pathophysiology and management of graft-versus-host disease in the era of reduced-intensity conditioning.
    Current opinion in oncology, 2009, Volume: 21 Suppl 1

    Topics: Alemtuzumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; An

2009
Corticosteroid regimens for treatment of acute and chronic graft versus host disease (GvHD) after allogenic stem cell transplantation.
    The Cochrane database of systematic reviews, 2010, Jan-20, Issue:1

    Topics: Acute Disease; Adrenal Cortex Hormones; Bone Marrow Transplantation; Chronic Disease; Graft vs Host

2010
Hepatocellular carcinoma in cirrhotic liver with graft-versus-host disease.
    Annals of hematology, 2012, Volume: 91, Issue:9

    Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chronic Disease; Combined Modality Therapy; Cyclospori

2012
Fulminant gastrointestinal graft-versus-host disease concomitant with cytomegalovirus infection: case report and literature review.
    World journal of gastroenterology, 2013, Jan-28, Volume: 19, Issue:4

    Topics: Adult; Antiviral Agents; Biopsy; Cytomegalovirus Infections; Endoscopy, Gastrointestinal; Female; Ga

2013
Diffuse proliferative glomerulonephritis after bone marrow transplantation.
    Clinical nephrology, 2002, Volume: 58, Issue:3

    Topics: Adolescent; Anti-Inflammatory Agents; Bone Marrow Transplantation; Glomerulonephritis, Membranoproli

2002
[GVHD].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 5

    Topics: Antilymphocyte Serum; Cyclosporine; Diagnosis, Differential; Drug Therapy, Combination; Graft vs Hos

2004
[Chronic graft-versus-host disease].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 5

    Topics: Animals; Autoimmunity; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Graft vs Host Disea

2005
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Bone marrow transplantation, 2001, Volume: 28, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation

2001
Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:7

    Topics: Adult; Bone Marrow Transplantation; Clarithromycin; Combined Modality Therapy; Cyclosporine; Debride

2001
Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9

    Topics: Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Drug Resi

2001
Acute and chronic graft-versus-host disease in man.
    International journal of cell cloning, 1986, Volume: 4 Suppl 1

    Topics: Acute Disease; Age Factors; Bone Marrow Transplantation; Chronic Disease; Cyclosporins; Drug Therapy

1986

Trials

18 trials available for prednisolone and Graft vs Host Disease

ArticleYear
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.
    Leukemia, 2021, Volume: 35, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Female; Follow-Up Studies; Graft v

2021
A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
    Blood, 2021, 05-13, Volume: 137, Issue:19

    Topics: Adult; Allografts; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Ther

2021
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD.
    Blood, 2013, Dec-12, Volume: 122, Issue:25

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Autoantibodies; Benzamides; Chronic Disease; Disease-F

2013
Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study.
    International journal of hematology, 2016, Volume: 103, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Child; Child, Preschool; Female; Graft vs Host Disease; Huma

2016
Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:3

    Topics: Administration, Buccal; Administration, Oral; Adult; Biological Availability; Biotransformation; Bud

2009
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
    Bone marrow transplantation, 2012, Volume: 47, Issue:12

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols;

2012
Endothelial vulnerability and endothelial damage are associated with risk of graft-versus-host disease and response to steroid treatment.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Aged; Endothelium, Vascular; Female; Glucocorticoids; Graft vs Host Disease; Hema

2013
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
    Blood, 2002, Dec-15, Volume: 100, Issue:13

    Topics: Adolescent; Adult; Analgesics; Cause of Death; Costs and Cost Analysis; Cyclosporine; Drug Utilizati

2002
Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants.
    Bone marrow transplantation, 2008, Volume: 41, Issue:7

    Topics: Adolescent; Adult; Bone Density; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Fem

2008
Treatment of graft-versus-host disease in human allogeneic marrow graft recipients: a randomized trial comparing antithymocyte globulin and corticosteroids.
    American journal of hematology, 1981, Volume: 11, Issue:1

    Topics: Adult; Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Transplantation; Clinical Trials

1981
Treatment of steroid-resistant graft-versus-host disease after allogeneic bone marrow transplantation with anti-CD3/TCR monoclonal antibodies.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal;

1995
FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Acute Disease; Adolescent; Adult; Azathioprine; Bone Marrow Transplantation; Child; Chronic Disease;

1995
FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.
    Bone marrow transplantation, 1995, Volume: 15, Issue:6

    Topics: Adolescent; Anti-Inflammatory Agents; Bone Marrow Transplantation; Child; Child, Preschool; Drug Res

1995
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in chronic phase following preparation with busulfan and cyclophosphamide.
    Bone marrow transplantation, 1994, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Combined Modality Therapy; Cyclopho

1994
Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation.
    Bone marrow transplantation, 1993, Volume: 12, Issue:5

    Topics: Adolescent; Adult; Antibodies, Monoclonal; Bone Marrow; Bone Marrow Transplantation; Child; Child, P

1993
Efficacy and safety of mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant recipient.
    Transplantation proceedings, 1998, Volume: 30, Issue:8

    Topics: Acute Disease; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Drug Therapy, Combination

1998
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients.
    Clinical transplantation, 2000, Volume: 14, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Bone Marrow Transplantation; Cyclosporine; Drug Combinations

2000
A prospective randomised trial of cyclosporin and methotrexate versus cyclosporin, methotrexate and prednisolone for prevention of graft-versus-host disease after HLA-identical sibling marrow transplantation for haematological malignancy.
    Australian and New Zealand journal of medicine, 1991, Volume: 21, Issue:6

    Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Chronic Disease;

1991

Other Studies

115 other studies available for prednisolone and Graft vs Host Disease

ArticleYear
Synthesis and antinephritic activities of quinoline-3-carboxamides and related compounds.
    Bioorganic & medicinal chemistry letters, 2002, Jan-07, Volume: 12, Issue:1

    Topics: Amides; Animals; Antibodies, Antinuclear; Autoimmune Diseases; Disease Models, Animal; Dose-Response

2002
Rare case of Stevens-Johnson syndrome with bronchiolitis obliterans as a chronic complication.
    BMJ case reports, 2022, Apr-25, Volume: 15, Issue:4

    Topics: Adolescent; Bronchiolitis Obliterans; Dyspnea; Female; Graft vs Host Disease; Humans; Prednisolone;

2022
[Steroid-refractory gastrointestinal acute graft-versus-host disease treated with vedolizumab and ruxolitinib in a pediatric patient with therapy-related acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023, Volume: 64, Issue:1

    Topics: Acute Disease; Child; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans

2023
[Anti-MDA5 antibody-positive rapidly progressive interstitial lung disease after allogeneic hematopoietic cell transplantation successfully treated with triple immunosuppressive therapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2023, Volume: 64, Issue:4

    Topics: Adult; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transp

2023
Simultaneous Determination of Prednisone and Prednisolone in Serum by Turbulent Flow Liquid Chromatography-Tandem Mass Spectrometry.
    Methods in molecular biology (Clifton, N.J.), 2024, Volume: 2737

    Topics: Chromatography, High Pressure Liquid; Chromatography, Liquid; Graft vs Host Disease; Humans; Prednis

2024
A case of hepatosplenic T-cell lymphoma successfully treated by HLA haploidentical stem cell transplantation.
    Journal of clinical and experimental hematopathology : JCEH, 2020, Jun-20, Volume: 60, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Graft vs Host Disease

2020
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Agammaglobulinemia; Age of Onset; Anemia, Hemolytic, Autoimmune; Child; Cyclosporine; Cytochrome P-4

2020
Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bilirubin; Biomarkers; Child; Female; Gra

2017
HTLV-I-associated posttransplant lymphoproliferative disorder following virus transmission from recipient to donor cells.
    Blood, 2017, 07-06, Volume: 130, Issue:1

    Topics: Allografts; Antigens, CD; Colitis; Disease Progression; Drug Resistance, Neoplasm; Female; Graft vs

2017
Urinary prednisolone excretion is a determinant of serum hepcidin levels in renal transplant recipients.
    American journal of hematology, 2017, Volume: 92, Issue:8

    Topics: Adult; C-Reactive Protein; Confounding Factors, Epidemiologic; Erythropoietin; Female; Ferritins; Gl

2017
T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia.
    International journal of hematology, 2018, Volume: 108, Issue:1

    Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Female; Follow-Up Studies; Graft vs Host

2018
Characterization of monocyte subtypes regarding their phenotype and development in the context of graft-versus-host disease.
    Transplant immunology, 2018, Volume: 50

    Topics: Adult; Aged; Cells, Cultured; Cholecalciferol; Female; Follow-Up Studies; Graft vs Host Disease; Hem

2018
Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for
    Frontiers in immunology, 2019, Volume: 10

    Topics: Adult; Agammaglobulinemia; Cyclosporine; Genetic Diseases, X-Linked; Graft vs Host Disease; Hematopo

2019
Entrapment syndrome of multiple nerves in graft-versus-host disease.
    Muscle & nerve, 2014, Volume: 49, Issue:1

    Topics: Comorbidity; Diagnosis, Differential; Fatal Outcome; Graft vs Host Disease; Humans; Immunosuppressiv

2014
Eosinophilic fasciitis following allogeneic bone marrow transplantation in a patient with acute myeloid leukaemia.
    Acta dermato-venereologica, 2014, Volume: 94, Issue:2

    Topics: Bone Marrow Transplantation; Diagnosis, Differential; Eosinophilia; Fascia; Fasciitis; Glucocorticoi

2014
T-cell chimerism is valuable in predicting early mortality in steroid-resistant acute graft-versus-host disease after myeloablative allogeneic cell transplantation.
    Acta haematologica, 2014, Volume: 132, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Allografts; Cyclophosphamide; Etoposide; Female; Graft Survival; G

2014
Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:9

    Topics: Acute Disease; Adult; Aged; Allografts; Chronic Disease; Dry Eye Syndromes; Female; Graft vs Host Di

2015
Fungal meningitis caused by Lomentospora prolificans after allogeneic hematopoietic stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:4

    Topics: Anti-Bacterial Agents; Antifungal Agents; Fatal Outcome; Glucocorticoids; Graft vs Host Disease; Hem

2016
Hemophagocytic lymphohistiocytosis following influenza vaccination in a patient with aplastic anemia undergoing allogeneic bone marrow stem cell transplantation.
    International journal of hematology, 2017, Volume: 105, Issue:4

    Topics: Adult; Allografts; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Dis

2017
Unrelated cord blood transplantation in children with severe congenital neutropenia.
    Pediatric transplantation, 2009, Volume: 13, Issue:6

    Topics: Child, Preschool; Cord Blood Stem Cell Transplantation; Graft vs Host Disease; HLA Antigens; Humans;

2009
Post-transplant EBV-related lymphoproliferative disorder complicating umbilical cord blood transplantation in patients of adrenoleukodystrophy.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Acyclovir; Adrenoleukodystrophy; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Ant

2009
[Massive pyogenic granuloma of the oral cavity during chronic graft-versus-host disease: treatment with local triamcinolone injection].
    Annales de dermatologie et de venereologie, 2009, Volume: 136, Issue:11

    Topics: Adrenal Cortex Hormones; Glucocorticoids; Graft vs Host Disease; Granuloma, Pyogenic; Humans; Inject

2009
Cutaneous Mycobacterium intracellulare infection in a bone marrow transplantation recipient.
    The Journal of dermatology, 2010, Volume: 37, Issue:2

    Topics: Bone Marrow Transplantation; Clarithromycin; Graft vs Host Disease; Humans; Immunocompromised Host;

2010
Late appearance of an acute graft-vs.-host disease reaction subsequent to a graft-vs.-tumor effect induced by bone marrow transplantation in a refractory ovarian carcinoma patient.
    International journal of dermatology, 2010, Volume: 49, Issue:3

    Topics: Bone Marrow Transplantation; CA-125 Antigen; Carcinoma, Papillary; Erythema; Fatal Outcome; Female;

2010
Membranoproliferative glomerulonephritis following allogeneic hematopoietic stem cell transplantation.
    Clinical and experimental nephrology, 2010, Volume: 14, Issue:6

    Topics: Adult; Azathioprine; Glomerulonephritis, Membranoproliferative; Graft vs Host Disease; Hematopoietic

2010
Acute but not chronic graft-versus-host disease is associated with a reduction of circulating CD4(+)CD25 (high)CD127 (low/-) regulatory T cells.
    Annals of hematology, 2011, Volume: 90, Issue:2

    Topics: Adult; Aged; Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; Female; Graft vs Host Di

2011
Once-weekly liposomal amphotericin B for prophylaxis of invasive fungal infection after graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: a comparative retrospective single-center study.
    Hematology/oncology and stem cell therapy, 2010, Volume: 3, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Drug Administr

2010
Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab.
    Modern rheumatology, 2011, Volume: 21, Issue:4

    Topics: Aged; Antibodies, Monoclonal, Humanized; Drug Therapy, Combination; Factor VIII; Female; Glucocortic

2011
[Acute lymphoblastic leukemia complicated with varicella zoster virus meningoencephalitis and visceral dissemination after related bone marrow transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:5

    Topics: Acute Kidney Injury; Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Chronic Diseas

2011
Hematopoietic stem cell transplantation with reduced intensity conditioning from a family haploidentical donor in an infant with familial hemophagocytic lymphohistocytosis.
    International journal of hematology, 2011, Volume: 94, Issue:3

    Topics: Female; Graft vs Host Disease; Haploidy; Hematopoietic Stem Cell Transplantation; Heterozygote; Huma

2011
Late-onset graft-versus-host disease after pediatric living-related liver transplantation for Langerhans cell histiocytosis.
    Pediatric transplantation, 2011, Volume: 15, Issue:6

    Topics: Adult; Antibodies, Monoclonal; Antilymphocyte Serum; Basiliximab; Biopsy; Bone Marrow Transplantatio

2011
Case of insulin edema occurring during intensive insulin therapy after bone marrow transplantation.
    The Journal of dermatology, 2012, Volume: 39, Issue:2

    Topics: Bone Marrow Transplantation; Diabetes Mellitus, Type 2; Edema; Female; Graft vs Host Disease; Humans

2012
Early occurrence of nephrotic syndrome associated with cord blood stem cell transplantation.
    Clinical and experimental nephrology, 2012, Volume: 16, Issue:1

    Topics: Bone Marrow Transplantation; Child; Child, Preschool; Cord Blood Stem Cell Transplantation; Graft vs

2012
Extensive gingival and respiratory tract Kaposi sarcoma in a child after allogenic hematopoietic stem cell transplantation.
    Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:2

    Topics: Child; Cyclosporine; Gingival Neoplasms; Graft vs Host Disease; Hematopoietic Stem Cell Transplantat

2012
Efficacy of pleural biopsy for diagnosis of pleural effusion due to chronic GVHD after hematopoietic stem cell transplantation.
    International journal of hematology, 2012, Volume: 96, Issue:1

    Topics: Biopsy; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged;

2012
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined C

2013
Imaging features of graft-versus-host disease: a rare cause of diffuse liver parenchymal disease.
    Hong Kong medical journal = Xianggang yi xue za zhi, 2013, Volume: 19, Issue:1

    Topics: Adolescent; Anemia, Aplastic; Dyskeratosis Congenita; Graft vs Host Disease; Hematopoietic Stem Cell

2013
A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
    American journal of hematology, 2002, Volume: 71, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azathioprine; Bone Marrow Trans

2002
Non-myeloablative haematopoietic stem cell transplantation for severe aplastic anaemia with various complications.
    Clinical and laboratory haematology, 2002, Volume: 24, Issue:5

    Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Female; Fractures, Bone; Graft Rejection; G

2002
Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
    Liver, 2002, Volume: 22, Issue:6

    Topics: Acute Disease; Adult; Bile Duct Diseases; Bone Marrow Transplantation; Cholagogues and Choleretics;

2002
Successful lithium carbonate treatment for steroid-induced depression following bone marrow transplantation: a case report.
    Japanese journal of clinical oncology, 2003, Volume: 33, Issue:10

    Topics: Adult; Antidepressive Agents; Bone Marrow Transplantation; Depressive Disorder; Female; Graft vs Hos

2003
Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies.
    Clinical and experimental immunology, 2003, Volume: 134, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Basiliximab; Coculture Techniques; Cyclos

2003
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 32, Issue:12

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo

2003
Rectal inflammation as first manifestation of graft-vs-host disease: radiologic-pathologic findings.
    European radiology, 2003, Volume: 13 Suppl 4

    Topics: Adult; Biopsy, Needle; Bone Marrow Transplantation; Cyclosporine; Drug Therapy, Combination; Female;

2003
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
    Bone marrow transplantation, 2004, Volume: 33, Issue:10

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Child; Chronic Disease; Cicatrix; Conjunctivitis; Diseas

2004
Pericarditis associated with Epstein-Barr virus reactivation in a patient following allogeneic peripheral blood stem cell transplantation from an HLA genotypic 1-locus mismatched sibling donor.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:2

    Topics: Adult; Electrocardiography; Female; Genotype; Graft vs Host Disease; Herpesvirus 4, Human; Humans; L

2004
Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation.
    Bone marrow transplantation, 2004, Volume: 34, Issue:1

    Topics: Adult; Biomarkers; Bone Density; Bone Marrow Transplantation; Bone Resorption; Cohort Studies; Cyclo

2004
Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation.
    Bone marrow transplantation, 2004, Volume: 34, Issue:11

    Topics: Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Child; Child, Preschool; Cord Blood Stem C

2004
[Hypercholesterolemia as a part of chronic GVHD after allogeneic stem cell transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:10

    Topics: Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft vs Host Disease; Humans; Hyp

2004
Unusual late pulmonary complication in a child after umbilical cord blood transplantation: high-resolution CT-pathologic correlation.
    Journal of thoracic imaging, 2005, Volume: 20, Issue:2

    Topics: Adolescent; Anti-Inflammatory Agents; Biopsy; Bronchiolitis; Cord Blood Stem Cell Transplantation; F

2005
Cicatricial pemphigoid of the oropharynx after allogeneic stem cell transplantation for relapsed follicular lymphoma.
    International journal of hematology, 2005, Volume: 82, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Female; Graft vs Host Disease; Humans; Lymphoma, Follicular; Mouth;

2005
The impact of immunosuppressive therapy on an early quantitative NK cell reconstitution after allogeneic haematopoietic cell transplantation.
    Annals of transplantation, 2005, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Antilymphocyte Serum; Child; Female; Flow Cytometry; Graft vs Host Disease; Hemat

2005
Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
    Haematologica, 2005, Volume: 90 Suppl

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic

2005
[Chronic GVHD with polymyositis after non-myeloablative stem cell transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:11

    Topics: Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, M

2005
Unrelated donor cord blood transplantation for childhood severe aplastic anemia after a modified conditioning.
    Pediatric transplantation, 2006, Volume: 10, Issue:4

    Topics: Anemia, Aplastic; Child; Cord Blood Stem Cell Transplantation; Female; Follow-Up Studies; Glucocorti

2006
Acute graft-versus-host disease of the lung with atypical presentation.
    International journal of hematology, 2006, Volume: 84, Issue:1

    Topics: Acute Disease; Anti-Inflammatory Agents; Azathioprine; Graft vs Host Disease; Hematopoietic Stem Cel

2006
Varicella-zoster virus encephalitis in a patient undergoing unrelated cord blood transplantation for myelodysplastic syndrome-overt leukemia.
    International journal of hematology, 2006, Volume: 84, Issue:1

    Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Cord Blood Stem Cell Transplantation;

2006
Polymyositis--an unusual presentation of cGvHD in children.
    Pediatric transplantation, 2007, Volume: 11, Issue:2

    Topics: Child, Preschool; Creatine Kinase; Female; Glucocorticoids; Graft vs Host Disease; Humans; Polymyosi

2007
Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome.
    Hematology (Amsterdam, Netherlands), 2006, Volume: 11, Issue:3

    Topics: Aclarubicin; Anemia, Refractory, with Excess of Blasts; Anti-Inflammatory Agents; Bone Marrow Transp

2006
Bullous pemphigoid positive for anti-BP180 and anti-laminin 5 antibodies in a patient with graft-vs-host disease.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:5 Suppl

    Topics: Autoantibodies; Autoantigens; Bone Marrow Transplantation; Cell Adhesion Molecules; Collagen Type XV

2007
Early-onset pulmonary complication showing organizing pneumonia pattern following cord blood transplantation in adults.
    International journal of hematology, 2007, Volume: 85, Issue:4

    Topics: Adult; Anti-Inflammatory Agents; Cord Blood Stem Cell Transplantation; Cryptogenic Organizing Pneumo

2007
Invasive fungal infection following reduced-intensity cord blood transplantation for adult patients with hematologic diseases.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2007, Volume: 13, Issue:7

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspergillosis, Allergic Bronchopulmonary; Cord Bl

2007
Clinical features of allogeneic hematopoietic stem cell transplantation-associated organizing pneumonia.
    Bone marrow transplantation, 2007, Volume: 40, Issue:5

    Topics: Adolescent; Adult; Aged; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic St

2007
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
    Transplantation, 2007, Aug-27, Volume: 84, Issue:4

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Child; Child, Preschool; Cyclosporine; Drug Therapy,

2007
Renal transplantation after removal and prevention of resynthesis of HLA antibodies.
    Lancet (London, England), 1984, Apr-14, Volume: 1, Issue:8381

    Topics: Adolescent; Adult; Antibody Formation; Autoantibodies; Cyclophosphamide; Female; Graft vs Host Disea

1984
Case report. Successful treatment of chronic cutaneous graft-versus-host-disease (GVHD) with penicillamine.
    Clinical and laboratory haematology, 1984, Volume: 6, Issue:4

    Topics: Adult; Azathioprine; Graft vs Host Disease; Humans; Male; Penicillamine; Prednisolone

1984
Graft-versus-host reaction in 3 adult leukaemia patients after transfusion of blood cell products.
    Scandinavian journal of haematology, 1983, Volume: 31, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubic

1983
Hematopoietic growth factors in rheumatoid arthritis: a critical approach to their use in view of possible adverse effects.
    The American journal of medicine, 1993, Volume: 94, Issue:2

    Topics: Adult; Arthritis, Rheumatoid; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disea

1993
Myasthenia gravis after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1994, Volume: 14, Issue:1

    Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Graft vs Host Disease; HLA-B7 Ant

1994
Cold agglutinin disease following allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1994, Volume: 13, Issue:3

    Topics: Adult; Anemia, Hemolytic, Autoimmune; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disea

1994
Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease.
    Bone marrow transplantation, 1993, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Bone Marrow Purging; Bone Marrow Transplantation; Cataract; Cataract Extraction;

1993
[Pulmonary disease as the chief manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:2

    Topics: Adolescent; Bone Marrow Transplantation; Chronic Disease; Graft vs Host Disease; Humans; Leukemia, M

1993
[Idiopathic interstitial pneumonitis possibly associated with chronic graft-versus-host disease].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:2

    Topics: Adult; Bone Marrow Transplantation; Chronic Disease; Female; Graft vs Host Disease; Humans; Male; Pr

1993
Donor buffy coat infusions for a patient with myelodysplastic syndrome who relapsed following allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1995, Volume: 16, Issue:3

    Topics: Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusion; Mal

1995
Donor leucocyte transfusions for relapse in myelodyplastic syndrome after allogeneic bone marrow transplantation.
    British journal of haematology, 1996, Volume: 93, Issue:2

    Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans; Leukocyte Transfusi

1996
Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.
    Bone marrow transplantation, 1996, Volume: 17 Suppl 2

    Topics: Adolescent; Adult; Blood Donors; Busulfan; Child; Child, Preschool; Cyclosporine; Erythropoietin; Fe

1996
Quadruple immunosuppression in a pig model of small bowel transplantation.
    The Journal of surgical research, 1996, Feb-15, Volume: 61, Issue:1

    Topics: Animals; Antilymphocyte Serum; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Graft R

1996
Donor leukocyte transfusions and discontinuation of immunosuppressants to achieve an initial remission after allogeneic bone marrow transplantation in a patient with primary refractory acute leukemia.
    Bone marrow transplantation, 1996, Volume: 18, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Clo

1996
Neurologic complications after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1996, Volume: 18, Issue:6

    Topics: Bone Marrow Transplantation; Brain Abscess; Busulfan; Cerebrovascular Disorders; Cyclosporine; Encep

1996
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
    Bone marrow transplantation, 1997, Volume: 19, Issue:5

    Topics: Acute Disease; Bone Marrow Transplantation; Cyclosporine; Extracorporeal Circulation; Female; Graft

1997
Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506.
    Bone marrow transplantation, 1997, Volume: 19, Issue:6

    Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Drug Resistance; Female; Graft vs Hos

1997
Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 1997, Volume: 10, Issue:5

    Topics: Azathioprine; Biological Availability; Cyclosporine; Drug Delivery Systems; Emulsions; Graft vs Host

1997
Intra-mesenteric artery steroid administration relieved severe refractory gastro-intestinal graft-vs.-host disease in an allogeneic bone marrow transplantation patient.
    American journal of hematology, 1997, Volume: 56, Issue:4

    Topics: Adult; Anemia, Aplastic; Bone Marrow Transplantation; Colitis, Ulcerative; Glucocorticoids; Graft vs

1997
A case of chronic graft-versus-host-disease following allogeneic peripheral blood stem cell rescue for poor graft function after bone marrow transplantation.
    The Korean journal of internal medicine, 1998, Volume: 13, Issue:1

    Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Chronic Disease; Cyclosporine; Female; Gr

1998
Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients.
    Bone marrow transplantation, 1998, Volume: 22, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Anemia; Bone Marrow Transplantation; Chronic Disease; Cyclosporine

1998
Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options.
    Bone marrow transplantation, 1998, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Anemia, Aplastic; Anti-Inflammatory Agents; Female; Graft vs Host Disease; Hemato

1998
Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation.
    Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host

1998
Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1999, Volume: 14, Issue:3

    Topics: Adult; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Cross-Sectional Studies; Cyclosporin

1999
Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Bone marrow transplantation, 1999, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Digestive System; Endoscopy, Gastrointestinal; Evaluation Studies as Topic; Femal

1999
Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation.
    Acta haematologica, 1999, Volume: 102, Issue:2

    Topics: Adjuvants, Immunologic; Adult; Bone Marrow Transplantation; Chronic Disease; Combined Modality Thera

1999
Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin.
    Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 1999, Volume: 5, Issue:3

    Topics: Acute Disease; Adolescent; Anti-Inflammatory Agents; Antilymphocyte Serum; Bone Marrow Transplantati

1999
Two cases of chronic graft-versus-host disease with elevated levels of soluble Fas ligand in serum.
    American journal of hematology, 2000, Volume: 64, Issue:2

    Topics: Adolescent; Chronic Disease; Cyclosporine; Fas Ligand Protein; Female; Graft vs Host Disease; Humans

2000
Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study.
    Bone marrow transplantation, 2000, Volume: 26, Issue:2

    Topics: Adult; Antineoplastic Agents; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; F

2000
Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin.
    Bone marrow transplantation, 2000, Volume: 26, Issue:8

    Topics: Administration, Oral; Adolescent; Bone Marrow Transplantation; Cryptogenic Organizing Pneumonia; Dru

2000
Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
    Cornea, 2001, Volume: 20, Issue:4

    Topics: Adult; Chronic Disease; Drug Therapy, Combination; Dry Eye Syndromes; Female; Glucocorticoids; Graft

2001
[Allogeneic bone marrow transplantation for refractory multiple myeloma: presence of a graft-versus-myeloma effect].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2001, Volume: 42, Issue:6

    Topics: Adult; Bone Marrow Transplantation; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Male; Mult

2001
Tresperimus (Laboratoires Fournier).
    Current opinion in investigational drugs (London, England : 2000), 2001, Volume: 2, Issue:3

    Topics: Animals; Carbamates; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Eva

2001
[Requirements for early discharge after allogeneic bone marrow transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2001, Volume: 42, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Female; G

2001
Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
    Endoscopy, 2001, Volume: 33, Issue:11

    Topics: Acute Disease; Adult; Cyclosporine; Endoscopy, Gastrointestinal; Gastrointestinal Diseases; Graft vs

2001
Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Adrenal Cortex Hormones; Alemtuzumab; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibod

2001
Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.
    Transplantation proceedings, 1978, Volume: 10, Issue:1

    Topics: Antilymphocyte Serum; Bone Marrow Transplantation; Graft vs Host Disease; Humans; Prednisolone; Pulm

1978
Membranous nephropathy with graft-versus-host disease in a bone marrow transplant recipient.
    Clinical nephrology, 1992, Volume: 37, Issue:3

    Topics: Adult; Antibodies, Antinuclear; Biopsy; Bone Marrow Transplantation; Cyclosporine; Fluorescent Antib

1992
Microangiopathic hemolytic anemia in a graft-versus-host disease patient treated with cyclosporine A and prednisolone.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:3

    Topics: Adult; Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Humans;

1992
Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
    Bone marrow transplantation, 1991, Volume: 7, Issue:1

    Topics: Administration, Oral; Animals; Bone Marrow Transplantation; Cyclosporins; Disease Models, Animal; Do

1991
FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.
    The Journal of antibiotics, 1987, Volume: 40, Issue:9

    Topics: Animals; Antibody Formation; Chemical Phenomena; Chemistry, Physical; Cyclosporins; Female; Fermenta

1987
Immune thrombocytopenia in dogs after fetal liver hematopoietic cell transplantation.
    Experimental hematology, 1989, Volume: 17, Issue:3

    Topics: Animals; Dogs; Female; Fetus; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transpl

1989
[Acute graft-versus-host disease in a patient with acute myeloblastic leukemia following consolidation therapy and platelet transfusions].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1988, Volume: 29, Issue:11

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyt

1988
Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections.
    Bone marrow transplantation, 1987, Volume: 1, Issue:3

    Topics: Adolescent; Adult; Aging; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relati

1987
[Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation--combination protocol of high dose methylprednisolone, prednisolone and methotrexate].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1986, Volume: 27, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Child, Preschool; Drug Therapy, Combi

1986
The use of the murine chronic graft vs host (CGVH) disease, a model for systemic lupus erythematosus (SLE), for drug discovery.
    Agents and actions, 1987, Volume: 21, Issue:3-4

    Topics: Animals; Cyclophosphamide; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Graft vs Ho

1987
[Allogeneic bone marrow transplantation after fractionated whole body irradiation. Results at the Kiel transplantation center].
    Deutsche medizinische Wochenschrift (1946), 1985, Sep-27, Volume: 110, Issue:39

    Topics: Acyclovir; Adolescent; Adult; Amphotericin B; Anemia, Aplastic; Bone Marrow Transplantation; Child;

1985
[Therapeutic aspects of cyclosporin in hematology].
    Revue medicale de Bruxelles, 1985, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Transplantation; Cyclos

1985
[Clinical picture of kidney transplantation. Surgical report].
    Langenbecks Archiv fur Chirurgie, 1968, Volume: 322

    Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Dactinomycin; Gastrointestinal Hemorrhage; Graft vs Hos

1968
[Proliferation of thymocytes after accidental involution].
    Verhandlungen der Deutschen Gesellschaft fur Pathologie, 1970, Volume: 54

    Topics: Animals; Cell Division; Graft vs Host Disease; Lymphatic Diseases; Lymphocytes; Male; Mice; Predniso

1970
[Kidney transplantation at Ullevål hospital. A 7 year material].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1971, May-30, Volume: 91, Issue:15

    Topics: Adult; Antigens; Corticosterone; Creatinine; Female; Follow-Up Studies; Graft vs Host Disease; Human

1971